SAM
ABMD

Strategy Asset Managers’s Abiomed Inc ABMD Stock Holding History

Strategy Asset Managers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,551
Closed -$404K – 141
2019
Q2 		$404K Sell
1,551
-5,697
-79% -$1.51M 0.11% 107
2019
Q1 		$2.07M Buy
7,248
+3,828
+112% +$1.27M 0.47% 79
2018
Q4 		$1.11M Sell
3,420
-3,095
-48% -$1.08M 0.27% 83
2018
Q3 		$2.93M Buy
+6,515
New +$2.57M 0.6% 53

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Strategy Asset Managers's ABMD Position: Q3 2019 in Review

Strategy Asset Managers sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,551 shares — an estimated $404K sold.

Strategy Asset Managers first reported a position in ABMD in Q3 2018 and held it in 4 quarters. The position peaked at $2.93M in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Strategy Asset Managers reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Strategy Asset Managers sold 1,551 Abiomed Inc shares in Q3 2019, an estimated $404K.
  • Strategy Asset Managers first reported a position in Abiomed Inc in Q3 2018 and held it in 4 quarters.
  • Strategy Asset Managers's Abiomed Inc position peaked at $2.93M in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Strategy Asset Managers's 13F filing for Q3 2019, filed 13 Nov 2019.